Bristol Myers inks protein degrader deal via Celgene team's link to seed-stage biotech
Bristol Myers Squibb is adding to its protein degrader lineup, which already includes the likes of A-Alpha Bio and Evotec, by linking arms with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
